RGD Reference Report - A synthetic analog of lipoxin A4 partially alleviates dexamethasone-induced fetal growth restriction in rats. - Rat Genome Database

Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources

A synthetic analog of lipoxin A4 partially alleviates dexamethasone-induced fetal growth restriction in rats.

Authors: Lin, F  Yu, X  Zhang, X  Guo, Y  Huang, Y  Zhou, J  Zeng, P  Ye, D  Huang, Y 
Citation: Lin F, etal., Placenta. 2013 Oct;34(10):941-8. doi: 10.1016/j.placenta.2013.07.007. Epub 2013 Aug 1.
RGD ID: 10412716
Pubmed: PMID:23910525   (View Abstract at PubMed)
DOI: DOI:10.1016/j.placenta.2013.07.007   (Journal Full-text)

Fetal growth restriction (FGR) is a major cause of neonatal morbidity and mortality. There is evidence to show that FGR is associated with oxidative stress. Lipoxin A4 (LXA4) is an anti-inflammatory mediator and is considered to be a potent endogenous "stop signal" in inflammation. LXA4 has been extensively studied preclinically in many diseases related to inflammation. Recently, the antioxidant effect of LXA4 on a variety of cell types has been reported. In the current study, we tested the effect of LXA4 on rats with experimental FGR. Dexamethasone (DEX) was administered to pregnant rats in order to induce FGR and BML-111, a synthetic analog of LXA4, was administrated as antioxidant therapy. DEX caused increased oxidative stress and trophoblast cell apoptosis in the placenta, leading to decreased placental weight and fetal weight at term. These effects were partially alleviated by BML-111. As a possible mechanism for this improvement in weight, BML-111 was found to promote nuclear translocation of nuclear factor erythroid 2-related factor 2 (Nrf2), up-regulate the expression of antioxidant enzyme genes, superoxide dismutase (SOD) and glutathione peroxidase (GPx), and consequently inhibited trophoblast cells apoptosis. This study demonstrates for the first time that LXA4 could potentially alleviate FGR in DEX-exposed pregnant rats.

RGD Manual Disease Annotations    Click to see Annotation Detail View
TermQualifierEvidenceWithReferenceNotesSourceOriginal Reference(s)
Fetal Growth Retardation treatmentISONfe2l2 (Rattus norvegicus)10412716; 10412716 RGD 
Fetal Growth Retardation treatmentIEP 10412716 RGD 

Objects Annotated

Genes (Rattus norvegicus)
Nfe2l2  (NFE2 like bZIP transcription factor 2)

Genes (Mus musculus)
Nfe2l2  (nuclear factor, erythroid derived 2, like 2)

Genes (Homo sapiens)
NFE2L2  (NFE2 like bZIP transcription factor 2)


Additional Information